Summary
A rigorous assessment of current practice in all branches of medicine is necessary to ensure that we are minimising the costs and maximising the effectiveness of management and treatment. This is especially important in cerebrovascular disease which imposes a large burden of death; it is the third commonest cause of death after cancer and heart disease in most developed countries, and the commonest cause of long term disability on society. Stroke consumes up to 5% of healthcare expenditure in developed countries, and costs can be expected to remain static or increase with an increase in the proportion of elderly (who are at high risk of stroke) in the community over coming decades.
This article reviews the epidemiology of stroke (risk factors, incidence, prevalence and the burden of disability and handicap), the various studies dealing with the community and individual costs of stroke, and the cost-effectiveness of interventions to prevent stroke such as control of hypertension, reduction in cigarette intake, encouragement of a healthy lifestyle, antiplatelet or anticoagulant therapy, and carotid endarterectomy. Acute treatment of stroke remains an area of major potential therapeutic benefit, but no widely applicable therapy currently exists, although many treatments are being investigated. Rehabilitation after stroke is costly, but may result in significant reduction in disability and handicap with reduced need for long term institutional care. The clinical implications of these studies and the potential for future research are also discussed.
Similar content being viewed by others
References
Adelman SM. Economic impact. National survey of stroke. Stroke 12 (Suppl. I): 169–178, 1981
Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, et al. Cerebrovascular disease in the community: results of a WHO Collaborative Study. Bulletin of the World Health Organization 58: 113–130, 1980
Aho K, Reunanen A, Aromaa A, Knekt P, Maatela J. Prevalence of stroke in Finland. Stroke 17: 681–686, 1986
Albrecht GL, Harasymiw SJ. Evaluating rehabilitation outcome by cost function indicators. Journal of Chronic Disease 32: 525–533, 1979
Allen CMC. Clinical diagnosis of the acute stroke syndrome. Quarterly Journal of Medicine 208: 515–523, 1983
American Nimodipine Study Group. Clinical trial of nimodipine in acute ischemic stroke. Stroke 23: 3–8, 1992
Amery A, Birkenhager W, Brixxo R, Bulpitt C, Clement D, et al. Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet 2: 589–592, 1986
Antiplatelet Trialists’ Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. British Medical Journal 296: 320–331, 1988
Ashok P, Radhakrishnan K, Sridharan R, El-Mangdush M. Incidence and pattern of cardiovascular diseases in Benghazi, Libya. Journal of Neurology, Neurosurgery and Psychiatry 49: 519–523, 1986
Asplund K. Randomized clinical trials of hemodilution in acute ischaemic stroke. Acta Neurologica Scandinavica (Suppl. 127): 22–30, 1989
Astrom M, Adolfsson R, Asplund K, Astrom T. Life before and after stroke: living conditions and life satisfaction in relation to a general elderly population. Cerebrovascular Diseases 2: 28–34, 1992a
Astrom M, Asplund K, Astrom T. Psychosocial function and life satisfaction after stroke. Stroke 23: 527–531, 1992b
Bamford J, Sandercock P, Warlow C, Gray M. Why are patients with acute stroke admitted to hospital? British Medical Journal 292: 1369–1372, 1986
Bamford J, Dennis M, Sandercock P, Burn J, Warlow C. The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project. Journal of Neurology, Neurosurgery, and Psychiatry. 53: 824–829, 1990a
Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981–1986. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. Journal of Neurology, Neurosurgery, and Psychiatry 53: 16–22, 1990b
Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337: 1521–1526, 1991
Bayer AJ, Pathy MSJ, Newcombe R. Double-blind randomised trial of intravenous glycerol in acute stroke. Lancet 1: 405–408, 1987
Blackbeard RR, Seeman HMI. Rehabilitation cost effectiveness of stroke. New Zealand Medical Journal 100: 109, 1990
Bloom BS. Medical management and managing medical care: the dilemma of evaluating new technology. American Heart Journal 119: 754–761, 1990
Bonaa KH, Bjerve KS, Straume B, Gram IT, Thelle D. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. New England Journal of Medicine 322: 795–801, 1990
Bonita R, Beaglehole R, North J. Event, incidence and case fatality rates of cerebrovascular disease in Auckland, New Zealand. American Journal of Epidemiology 120: 236–243, 1984
Bonita R, Scragg R, Stewart A, Jackson R, Beaglehole R. Cigarette smoking and risk of premature stroke in men and women. British Medical Journal 293: 6–8, 1986
Bonita R, Beaglehole R. The decline in stroke mortality: the limited role of antihypertensive therapy. New Zealand Medical Journal 100: 454–456, 1987
Bonita R, Anderson A, North JDK. The pattern of management after stroke. Age and Ageing 16: 29–34, 1987
Bonita R, Stewart A, Beaglehole R. International trends in stroke mortality: 1970–1985. Stroke 21: 989–992, 1990
Bonita R, Beaglehole R. Hospital bed use by stroke patients: the Auckland stroke study. New Zealand Medical Journal 101: 497–499, 1988
Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. New England Journal of Medicine 323: 1505–1511, 1990
Britton M, Hindmarsh T, Murray V, Tyden SA. Diagnostic errors discovered by CT in patients with suspected stroke. Neurology 34: 1504–1507, 1984
Britton M, Jonsson E, Marke LA, Murray V. Diagnosing suspected stroke: a cost-effectiveness analysis. International Journal of Technology Assessment. 1: 147–158, 1985
Broderick JP, Phillips SJ, Whisnant JP, O’Fallon WM, Bergstrahl EJ. Incidence rates of stroke in the eighties: the end of the decline in stroke? Stroke 20: 577–582, 1989
Bryant NH, Candland L, Loewenstein R. Comparison of care and cost outcomes for stroke patients with and without home care. Stroke 5: 54–59, 1974
Burnett PJ, Milne JR, Greenwood R, Giles MR, Camm J. The role of echocardiography in the investigation of focal cerebral ischaemia. Postgraduate Medical Journal 60: 116–119, 1984
Carstairs V. Stroke: Resource consumption and cost to the community. In Gillingham FJ et al. (Eds) Stroke: proceedings of the ninth international Pfizer symposium,. Churchill Livingstone, Edinburgh, 1976
Casanova Study Group. Carotid surgery versus medical therapy in asymptomatic carotid stenosis. Stroke 22: 1229–1235, 1991
Cebul RD, Whisnant JP. Carotid endarterectomy. Annals of Internal Medicine 111: 660–670, 1989
Cerebral Embolism Task Force (CETF). Cardiogenic brain embolism. Archives of Neurology 43: 71–84, 1986
Chambers BR, Norris JW. Outcome in patients with asymptomatic neck bruits. New England Journal of Medicine 315: 860–865, 1986
Christie D. Prevalence of stroke and its sequelae. Medical Journal of Australia 2: 182–184, 1981
Colandrea MA, Friedman GD, Nichaman MZ, Lynd CN. Systolic hypertension in the elderly: an epidemiologic assessment. Circulation 41: 239–245, 1970
Colgan MP, Strode GR, Sommer JD, Gibbs JL, Sumner DS. Prevalence of asymptomatic carotid disease: results of duplex scanning in 348 unselected volunteers. Journal of Vascular Surgery 8: 674–678, 1988
Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, et al. Blood pressure, stroke, and coronary heart disease. Part 2. Shortterm reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335: 827–838, 1990
Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, et al. Canadian Atrial Fibrillation Anticoagulation (CAFA) study. Journal of the American College of Cardiology 18: 349–355, 1991
Coope J, Warrender TS, McPherson K. The prognostic significance of blood pressure in the elderly. Journal of Human Hypertension 2: 79–88, 1988
Cooper R, Sempos C, Hsieh S-C, Kovar MG. Slowdown in the decline of stroke mortality in the United States, 1978–1986. Stroke 21: 1274–1279, 1990
Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, et al. Theeffects of antihypertensive therapy on the quality of life. New England Journal of Medicine 314: 1657–1664, 1986
Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet 1: 581–584, 1987
Cummings V. An evaluation of a day hospital in rehabilitation medicine. Executive summary. National Center for Health Sciences Research Hyattsville, 1981
Davey PJ, Leeder SR. The cost of migraine: more than just a headache? PharmacoEconomics 2: 5–7, 1992
David R, Enderby P, Bainton D. Treatment of acquired aphasia: speech therapists and volunteers compared. Journal of Neurology, Neurosurgery and Psychiatry 45: 957–961, 1982
Davies P, Bamford J, Warlow C. Remedial therapy and functional recovery in a total population of first-stroke patients. International Disability Studies 11: 40–44, 1989
Dayton S, Pearce ML, Hashimoto S, Dixon WJ, Tomiyasu U. A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation 40 (Suppl. II): II1–II63, 1969
deBelder MA, Lovat LB, Tourikis L, Leech G, Camm AJ. Limitations of transoesophageal echocardiography in patients with focal cerebral ischaemic events. British Heart Journal 67: 297–303, 1992
Dennis MS, Bamford JM, Sandercock PAG, Warlow CP. Incidence of Transient Ischaemic Attacks in Oxfordshire, England. Stroke 20: 333–339, 1989
Detsky AS, Naglie IG. A clinician’s guide to cost-effectiveness analysis. Annals of Internal Medicine 113: 147–154, 1990
Dixon J, Welch HG. Priority setting: lessons from Oregon. Lancet 337: 891–894, 1991
Drummond MF, Ward GH. The financial burden of stroke and the economic evaluation of treatment alternatives. Rose FC (Ed.) Stroke: epidemiological, therapeutic and socio-economic aspects. Royal Society of Medicine Services International Congress and Symposium Series 99, London, 1986
Drummond M, Stoddart G, Labelle R, Cushman R. Health economics: an introduction for clinicians. Annals of Internal Medicine 107: 88–92, 1987
Drummond MF. Allocating resources. International Journal of Technology Assessment in Health Care 6: 77–92, 1990
Drummond MF. Cost-of-illness studies: a major headache? PharmacoEconomics 2: 1–4, 1992
Dunbabin DW, Sandercock PAG. Preventing stroke by the modification of risk factors. Stroke 21 (Suppl. IV): IV–36–IV39, 1990
Dunbabin DW, Sandercock PAG. Investigation of acute stroke: what is the most effective strategy? Postgraduate Medical Journal 67: 259–270, 1991
Ebrahim S. Clinical epidemiology of stroke. Oxford Medical Publications, Oxford University Press, 1990
Edgar MA, Schnieden H. The economics of mild hypertension programmes. Social Science Medicine 28: 211–222, 1989
Edwards WH, Morris JA, Jenkins JM, Bass SM, MacKenzie EJ. Evaluating quality, cost-effective health care: vascular database predicated on hospital discharge abstracts. Annals of Surgery 213: 433–438, 1991
Eisenberg JM. Physician utilization: the state of research about physician’s practice patterns. Medical Care 23: 461–483, 1985
European Carotid Surgery Trialists’ Collaborative Group. MRC European Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet 337: 1235–1243, 1991
Evans DB. Principles involved in costing. Medical Journal of Australia 153 (Suppl): S10–S12, 1990
Farquhar JW, Fortmann SP, Flora JA, Taylor CB, Haskell WL, et al. Effects of communitywide education on cardiovascular risk factors: the Stanford five-city project. Journal of the American Medical Association. 264: 359–365, 1990
Feigenson JS, McCarthy ML, Meese PD, Feigenson WD, Greenberg SD, et al. Stroke Rehabilitation. 1. Factors predicting outcome and length of stay — an overview. New York State Journal of Medicine 77: 1426–1430, 1977
Feigenson JS, Feigenson WD, Gitlow HS, McCarthy ML, Greenberg SD. Outcome and cost for stroke patients in academic and community hospitals: comparison of two groups referred to a regional rehabilitation center. Journal of the American Medical Association 240: 1878–1880, 1978
Feigenson JS, Gitlow HS, Greenberg SD. The disability oriented rehabilitation unit — a major factor influencing stroke outcome. Stroke 10: 5–7, 1979
Feldman DJ, Lee PR, Unterecker J, Lloyd K, Rusk HA, et al. A comparison of functionally orientated medical care and formal rehabilitation in the management of patients with hemiplegia due to cerebrovascular disease. Journal of Chronic Disease 15: 297–310, 1962
Fields WS, Maslenikov V, Meyer JS, Hass WK, Remington RD et al. Joint study of extracranial arterial occlusion. Progress report of prognosis following surgery or non-surgical treatment for transient cerebral ischaemic attacks and cervical carotid artery lesions. Journal of the American Medical Association 211: 1993–2003, 1970
Finkler SA. The distinction between cost and charges. Annals of Internal Medicine 96: 102–109, 1982
Flegel KM, Shipley MJ, Rose G. Risk of stroke in non-rheumatic atrial fibrillation. Lancet 1: 526–529, 1987
Forster A, Young J. Day hospital and stroke patients. International Disability Studies 11: 181–183, 1989
Garde A, Samuelsson K, Fahlgren H, Hedberg E, Hjerne LG, et al. Treatment after transient ischaemic attacks: a comparison between anticoagulant drug and inhibition of platelet aggregation. Stroke 14: 677–681, 1983
Garraway WM, Whisnant JP, Furlan AJ, Phillips LH, Kurland LT, et al. The declining incidence of stroke. New England Journal of Medicine 300: 449–452, 1979
Garraway WM, Akhtar AJ, Prescott RJ, Hockey L. Management of acute stroke in the elderly: preliminary results of a controlled trial. British Medical Journal 280: 1040–1043, 1980a
Garraway WM, Akhtar AJ, Hockey L, Prescott RJ. Management of acute stroke in the elderly: follow-up of a controlled trial. British Medical Journal 281: 827–829, 1980b
Garraway WM, Whisnant JP, Drury I. The changing pattern of survival following stroke. Stroke 14: 699–703, 1983a
Garraway WM, Whisnant JP, Drury I. The continuing decline in the incidence of stroke. Mayo Clinic Proceedings 58: 520–523, 1983b
Gent M, Blakely JA, Easton JO et al. The Canadian American Ticlopidine Study (CATS) in thromboembolytic stroke. Lancet 1: 1215–1220, 1989
Genton E, Barnett H, Fields W. Cerebral ischaemia: the role of thrombosis and antithrombotic therapy. Stroke 8: 150–175, 1977
Ginsberg GM, Viskoper RJ, Oren S, Bregman L, Mishal Y, et al. Resource savings from non-pharmacological control of hypertension. Journal of Human Hypertension 4: 375–378, 1990
Gordon EE, Kohn KH. Evaluation of rehabilitation methods in the hemiplegic patient. Journal of Chronic Diseases 19: 3–16, 1966
Granger CV, Kaplan MT, Jones B, Bell N. Stroke: comparison of admissions in a community hospital. Archives of Physical and Medical Rehabilitation 63: 352–356, 1982
Gray CS, French JM, Venables GS, Cartlidge NEF, James OFW, et al. A randomized double-blind controlled trial of Naftidrofuryl in acute stroke. Age and Ageing 19: 356–363, 1990
Green RM, McNamara J. Optimal resources for carotid endarterectomy. Surgery 102: 743–747, 1987
Greenland P, Knopman DS, Mikell FL, Asinger RW, Anderson DC, et al. Echocardiography in the assessment of stroke. Annals of Internal Medicine 95: 51–53, 1981
Hall JP, Heller RF, Dobson AJ, Lloyd DM, Sanson-Fisher RW, et al. A cost-effectiveness analysis of alternative strategies for the prevention of heart disease. Medical Journal of Australia 148: 273–277, 1988
Hamrin E. II. Early activation in stroke: does it make a difference? Scandinavian Journal of Rehabilitation Medicine 14: 101–116, 1982
Hankey GJ, Warlow CP, Sellar RJ. Cerebral angiographic risk in mild cerebrovascular disease. Stroke 21: 209–222, 1990
Hankey GJ, Warlow CP. Symptomatic carotid ischaemic events: safest and most cost effective way of selecting patients for angiography, before carotid endarterectomy. British Medical Journal 300: 1485–1491, 1990
Hankey GJ, Slattery JM, Warlow CP. The prognosis of hospitalreferred transient ischaemic attacks. Journal of Neurology, Neurosurgery and Psychiatry. 54: 793–802, 1991
Hankey GJ, Warlow CP. Prognosis of symptomatic carotid artery occlusion: an overview. Cerebrovascular Diseases 1: 245–256, 1991
Hankey GJ, Warlow CP. Cost-effective investigation of patients with suspected transient ischaemic attacks. Journal of Neurology, Neurosurgery, and Psychiatry. 55: 171–176, 1992
Hartunian NS, Smart CN, Thompson MS. The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease and stroke: a comparative analysis. American Journal of Public Health 70: 1249–1260, 1980
Hazelton AE, Earnest MP. Impact of computed tomography on stroke management and outcome. Archives of Internal Medicine 147: 217–220, 1987
Hennekens CH, Buring JE, Sandercock PAG, Collins RC, Peto R. Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. Circulation 80: 749–756, 1989
Herman B, Leyten A, van Luijk et al. Epidemiology of stroke in Tillburg, the Netherlands. The population-based stroke registry. 2. Incidence, initial clinical picture and medical care, and three-week case fatality. Stroke 13: 629–634, 1982
Hewer RL. Rehabilitation after stroke. Quarterly Journal of Medicine 279: 659–674, 1990
Hodgson TA, Meiners MR. Cost-of-illness methodology: a guide to current practices and procedures. Millbank Memorial Fund Quarterly 60: 429–459, 1982
Hopkins A, Menken M, DeFriese GH, Feldman RG. Differences in strategies for the diagnosis and treatment of neurologic disease among British and American neurologists. Archives of Neurology 46: 1142–1148, 1989
House A. Depression after stroke. British Medical Journal 294: 76–78, 1987
House A, Dennis M, Molyneux A, Warlow C, Hawton K. Emotionalism after stroke. British Medical Journal 298: 991–994, 1989
Hsu CY, Norris JW, Hogan EL, Bladin P, Dinsdale HB, et al. Pentoxifylline in acute nonhemorrhagic stroke: a randomized, placebo-controlled double-blind trial. Stroke 19: 716–722, 1988
Humphrey P, Sandercock P, Slattery J. A simple method to improve the accuracy of noninvasive ultrasound in selecting TIA patients for cerebral angiography. Journal of Neurology, Neurosurgery and Psychiatry 53: 966–971, 1990
Hypertension Prevention Trial Research Group. The hypertension prevention trial: three-year effects of dietary changes on blood pressure. Archives of Internal Medicine 150: 153–162, 1990
Hypertension-Stroke Cooperative Study Group. Effect of antihypertensive treatment on stroke recurrence. Journal of the American Medical Association 229: 409–418, 1974
Indredavik B, Bakke F, Solberg R, Rokseth R, Haaheim LL, et al. Benefit of a stroke unit: a randomized controlled trial. Stroke 22: 1026–1031, 1991
Isard PA, Forbes JF. The cost of stroke to the National Health Service in Scotland. Cerebrovascular Diseases 2: 47–50, 1992
Iso H, Jacobs DR, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. New England Medical Journal 320: 904–909, 1989
Italian Acute Stroke Study Group. Haemodilution in acute stroke. Lancet 1: 318–320, 1988
Jaeschke R, Guyatt GH, Cook D. Quality of life instruments in the evaluation of new drugs. PharmacoEconomics 1: 84–93, 1992
Johnston MV, Keith RA. Cost-benefits of medical rehabilitation: review and critique. Archives of Physical and Medical Rehabilitation 64: 147–154, 1983
Kannel WB, Wolf PA, McGee DL, Dawber TR, McNamara P, et al. Systolic blood pressure, arterial rigidity, and risk of stroke: the Framingham study. Journal of the American Medical Association 245: 1225–1229, 1981
Kawachi I. Economic factors in the initiation of antihypertensive therapy. PharmacoEconomics 2: 324–334, 1992
Kawachi I, Malcolm LA. The cost-effectiveness of treating mild-to-moderate hypertension: a reappraisal. Journal of Hypertension 9: 199–208, 1991
Kilpatrick CJ, Davis SM, Tress BM, Rossiter SC, Hopper JL, et al. Epileptic seizures in acute stroke. Archives of Neurology 47: 157–160, 1990
Klag MJ, Whelton PK, Seidler AJ. Decline in US stroke mortality: demographic trends and antihypertensive treatment. Stroke 20: 14–21, 1989
Kotila M. Declining incidence of stroke? Stroke 15: 255–259, 1984
Krakoff LR, Schecter C, Fahs M. Ambulatory blood pressure monitoring: is it cost-effective? Journal of hypertension 9 (Suppl 8): 528–530, 1991
Labi MLC, Phillips TF, Gresham GE. Psychosocial disability in physically restored long-term stroke survivors. Archives of Physical Medicine and Rehabilitation 61: 561–565, 1980
Larson EB, Omenn GS, Loop JW. Computed tomography in patients with cerebrovascular disease: impact of a new technology on patient care. American Journal of Roentgenology 131: 35–40, 1978
Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III-Analysis of data from trials of salt reduction. British Medical Journal 302: 819–824, 1991
Lehmann JF, DeLateur, Fowler RS, Warren CG, Arnhold R, et al. Stroke: does rehabilitation affect outcome? Archives of Physical Medicine and Rehabilitation 56: 375–382, 1975
Lincoln NB, McGuirk E, Mulley GP, Lendrem W, Jones AC, et al. Effectiveness of speech therapy for aphasic stroke patients: a randomised controlled trial. Lancet 1: 1197–1200, 1984
Lind K. A synthesis of studies on stroke rehabilitation. Journal of Chronic Disease 35: 133–149, 1982
Lindenstrom E, Boysen G, Nyboe J, Appleyard M. Stroke incidence in Copenhagen, 1976–1988. Stroke 23: 28–32, 1992
Loewy EH. Cost should not be a factor in medical care. New England Journal of Medicine 302: 697, 1980
Lovett JL, Sandok BA, Giuliani ER, Nasser FN. Two-dimensional echocardiography in patients with focal cerebral ischaemia. Annals of Internal Medicine 95: 1–4, 1981
MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, et al. Blood pressure, stroke and coronary heart disease. Part I: Effects of prolonged differences in blood pressure — evidence from nine prospective epidemiological studies corrected for regression dilution bias. Lancet 335: 765–774, 1990
Malcolm LA, Kawachi I, Jackson R, Bonita R. Is the pharmacological treatment of mild to moderate hypertension cost effective in stroke prevention? New Zealand Medical Journal 101: 167–171, 1988
Malmgren R, Warlow C, Bamford J, Sandercock P. Geographical and secular trends in stroke incidence. Lancet 2: 1196–1200, 1987
Malmgren R, Bamford J, Warlow C, Sandercock P, Slattery J. Projecting the number of patients with first ever strokes and patients newly handicapped by stroke in England and Wales. British Medical Journal 298: 656–660, 1989
Manton KG. The global impact of noncommunicable diseases: Estimates and projections. World Health Statistical Quarterly 41: 255–266, 1988
Marmot MG, Poulter NR. Primary prevention of stroke. Lancet 339: 344–347, 1992
Marsh EE, Adams HP, Biller J, Wasek P, Banwart K, et al. Use of antithrombotic drugs in the treatment of acute ischemic stroke: a survey of neurologists in practice in the United States. Neurology 39: 1631–1634, 1989
Martens LL, Rutten FFH, Erkelens DW, Ascoop CAPL. Cost effectiveness of cholesterol-lowering therapy in the Netherlands: simvastatin versus cholestyramine. American Journal of Medicine 87 (Suppl. 4A): 54S–58S, 1989
Mattila K, Haavisto M, Rajala S, Heikinheimo R. Blood pressure and five year survival in the very old. British Medical Journal 296: 887–889, 1988
McCann BC, Culbertson RA. Comparison of two systems for stroke rehabilitation in a general hospital. Journal of the American Geriatrics Society 24: 211–216, 1976
McCarthy ST, Turner JJ, Robertson D, Hawkey CJ. Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke. Lancet 2: 800–801, 1977
Medical Research Council Working Party. Stroke and coronary heart disease in mild hypertension: risk factors and the value of treatment. British Medical Journal 296: 1565–1570, 1988
Merrick NJ, Brook RH, Fink A, Solomon DH. Use of carotid endarterectomy in five California Veterans Administration medical centers. Journal of the American Medical Association 256: 2531–2535, 1986
Millar JA, Hansen PC. Economic costs and benefits of treating mild hypertension: results from a cross-sectional model. New Zealand Medical Journal 101: 623–625, 1988
Mills E, Thompson M. The economic costs of stroke in Massachusetts. New England Journal of Medicine 299: 415–418, 1978
National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 21: 637–676, 1990
Neal WW. Reducing costs and improving compliance. American Journal of Cardiology 63: 17B–20B, 1989
Nissinen A, Tuomilehto J, Kottke TE, Puska P. Cost-effectiveness of the North Karelia Hypertension Program 1972–1977. Medical Care 24: 767–780, 1986
Nissinen A, Bothig S, Granroth H. Hypertension in developing countries. World Health Statistics Quarterly 41: 141–157, 1988
North American Symptomatic Carotid Endarterectomy Trial Collaborators (NASCET). Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. New England Journal of Medicine. 325: 445–453, 1991
Olsson JE, Brechter C, Backlund H, Krook H, Muller R, et al. Anticoagulant vs antiplatelet therapy as prophylactic against cerebral infarction in transient ischaemic attacks. Stroke 11: 4–9, 1980
Osberg JS, McGinnis GE, DeJong G, Seward ML, Germaine J. Long-term utilization and charges among post-rehabilitation stroke patients. American Journal of Physical Medicine and Rehabilitation 67: 66–72, 1988
Osberg JS, Haley SM, McGinnis GE, DeJong G. Characteristics of cost outliers who did not benefit from stroke rehabilitation. American Journal of Physical Medicine and Rehabilitation. 69: 117–125, 1990
Oster G, Epstein AM. Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease: the case of cholestyramine. Journal of the American Medical Association. 258: 2381–2387, 1987
Pauker SG, Eckman MH, Levine HJ. A decision analytic view of anticoagulant prophylaxis for thromboembolism in heart disease. Chest 95 (Suppl. 2); 161S–169S, 1989
Peacock PB, Riley CP, Lampton TD, Raffael SS, Walker JS. The Birmingham stroke epidemiology and rehabilitation study. Stewart CT. Trends in Epidemiology: application to health services research and training. 231–345 CC Thomas, Springfield, 1972
Persson U, Silverberg R, Lindgren B, Norvving B, Jadback G, et al. Direct costs of stroke for a Swedish population. International Journal of Technology Assessment in Health Care 6: 125–137, 1990
Pessin MS, DelZoppo GJ, Estol CJ. Thrombolytic agents in the treatment of stroke. Clinical Neuropharmacology 13: 271–289, 1990
Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. Lancet 1: 175–179, 1989
Phillips SJ. Is atrial fibrillation an independent risk factor for stroke? Canadian Journal of Neurological Science 17: 163–168, 1990
Pop G, Sutherland GR, Koudstaal PJ, Sit TW, deJong G, et al. Transesophageal echocardiography in the detection of intracardiac embolic sources in patients with transient ischemic attacks. Stroke 21: 560–565, 1990
Poungvarin N, Viriyavejakul A, Komontri C. Siriraj stroke score and validation study to distinguish supratentorial intracerebral haemorrhage from infarction. British Medical Journal 302: 1565–1567, 1991
Qizilbash N, Warlow CP, Mann J. Fibrinogen and lipids as risk factors for ischaemic stroke: a case control study. Abstract. Journal of Neurology 237: 143, 1990
Rasmussen D, Kohler O, Worm-Petersen S, Blegvad N, Jacobsen HL, et al. Computed tomography in prognostic stroke evaluation. Stroke 23: 506–510, 1992
Ricci S, Celanti MG, Guencini G et al. First year results of a community-based study of stroke incidence in Umbria, Italy. Stroke 20: 853–857, 1989
Robbins JA, Sagar KB, French M, Smith PJ. Influence of echocardiography on mangement of patients with systemic emboli. Stroke 14: 546–549, 1983
Rogvi-Hansen B, Boysen G. Intravenous glycerol treatment of acute stroke-a statistical review. Cerebrovascular Diseases 2: 11–13, 1992
Rose G. Strategy of prevention: lessons from cardiovascular disease. British Medical Journal 282: 1847–1851, 1981
Rose G, Colwell L. Randomised controlled trial of anti-smoking advice: final (20 year) results. Journal of Epidemiology and Community Health 46: 75–77, 1992
Sacco RL, Wolf PA, Kannel WB, McNamara PM. Survival and recurrence following stroke: The Framingham study. Stroke 13: 290–296, 1982
Sackett DL, Haynes RB, Tugwell P. Clinical epidemiology: a basic science for clinical medicine, Little, Brown and Company, Boston 1985
Sandercock P, Molyneux A, Warlow C. Value of computed tomography in patients with stroke: Oxfordshire Community Stroke Project. British Medical Journal 290: 193–197, 1985
Sandercock PAG, Warlow CP, Jones LN, Starkey IR. Predisposing factors for cerebral infarction: the Oxfordshire community stroke project. British Medical Journal 298: 75–80, 1989
Sarno MT, Silverman M, Sands E. Speech therapy and language recovery in severe aphasia. Journal of Speech and Hearing Research 13: 607–623, 1970
Sekita Y. Cost-benefit evaluation of comprehensive medical care for cerebral strokes. Medical Information 10: 59–71, 1985
Shafi M, Mayberry J, Calcraft B. An audit of a medical anticoagulant clinic in a district general hospital. Postgraduate Medical Journal 59: 492–494, 1983
Shenkin HA, Zavala M. Cerebellar strokes: mortality, surgical indications, and results of ventricular drainage. Lancet 2: 429–432, 1982
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). Journal of the American Medical Association 265: 3255–3264, 1991
Shi F, Hart RG, Sherman DG, Tegeler CH. Stroke in the People’s Republic of China. Stroke 20: 1581–1585, 1989
Shigan EN. Integrated programme for noncommunicable diseases prevention and control. World Health Statistics Quarterly 41: 267–272, 1988
Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. British Medical Journal 298: 789–794, 1989
Siani A, Strazzullo P, Russo L, Guglielmi S, Iacoviello L, et al. Controlled trial of long term oral potassium supplements in patients with mild hypertension. British Medical Journal 294: 1453–1456, 1987
Silliman RA, Wagner EH, Fletcher RH. The social and functional consequences of stroke for elderly patients. Stroke 18: 200–203, 1987
Simes RJ. Meta-analysis: its importance in cost-effectiveness studies. Proceedings of a symposium on measurement of cost-effectiveness of drug therapy, Melbourne, July, 1989. Medical Journal of Australia 153 (Suppl.): S13–S15, 1990
Simes RJ, Glasziou PP. Meta-analysis and quality of evidence in the economic evaluation of drug trials. PharmacoEconomics 1: 282–292, 1992
Sivenius J, Pyorala K, Heinonen OP, Salonen JT, Reikkinen P. The significance of intensity of rehabilitation of stroke — a controlled trial. Stroke 16: 928–931, 1985
Smith DS, Goldenberg E, Ashburn A. Remedial therapy after stroke: a randomised controlled trial. British Medical Journal 282: 517–520, 1981
Smith WCS, Lee AJ, Crombie IK, Tunstall-Pedoe H. Control of blood pressure in Scotland: the rule of halves. British Medical Journal 300: 981–983, 1990
Sofaer S, Kenney E. Financial consequences of joining a Medicare HMO: an application of the illness episode approach to estimating out-of-pocket costs. Journal of Health Politics, Policy and Law 14: 565–581, 1989
Sotaniemi KA, Pyhtinen J, Myllyla VV. Correlation of clinical and computed tomographic findings in stroke patients. Stroke 21: 1562–1566, 1990
Staessen J, Bulpitt C, Clement D, DeLeeuw P, Fagard R, et al. Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly. British Medical Journal 298: 1552–1556, 1989
Stamler R, Stamler J, Gosch FC, Civinelli J, et al. Primary prevention of hypertension by nutritional-hygenic means: final report of a randomized, controlled trial. Journal of the American Medical Association. 262: 1801–1807, 1989
Stamp EJ, Jones SJ, Ryrie DR, Hedley AJ. Oral anticoagulants: a cost-effectiveness approach. Journal of the Royal College of Physicians of London 19: 105–108, 1985
Stason WB, Weinstein MC. Allocation of resources to manage hypertension. New England Journal of Medicine 296: 732–739, 1977
Steiner TJ, Rose FC. Towards a model stroke trial: the singlecentre naftidrofuryl study. Neuroepidemiology 5: 121–147, 1986
Steinke W, Kloetzsch C, Hennerici M. Carotid artery disease assessed by color doppler flow imaging: correlation with standard doppler sonography and angiography. American Journal of Neuroradiology 11: 259–266, 1990
Steven ID, Wilson DH, Wakefield MA, Beilby J, Coffey GA, et al. South Australian hypertension survey: general practitioner knowledge and reported management practices — a cause for concern? Medical Journal of Australia 156: 423–428, 1992
Stevens RS, Ambler NR, Warren MD. A randomized controlled trial of a stroke rehabilitation ward. Age and Ageing 13: 65–75, 1984
Strand T, Asplund K, Eriksson S, Hagg E, Lithner F, Wester PO. A non-intensive stroke unit reduces functional disability and the need for long-term hospitalization. Stroke 16: 29–34, 1985
Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study: final results. Circulation 84: 527–539, 1991
Stroke Prevention in Atrial Fibrillation Investigators. Predictions of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. Annals of Internal Medicine 116: 1–12, 1992
Tanaka H. Age-specific incidence of stroke subtype in Shibata, Japan: 1976–1978. Stroke 13: 110, 1982
Tarbit IF. Costing clinical biochemistry services as part of an operational management budgeting system. Journal of Clinical Pathology 39: 817–827, 1986
Taylor JO, Cornoni-Huntley J, Curb JD, Manton KG, Ostfeld AM, et al. Blood pressure and mortality risk in the elderly. American Journal of Epidemiology 134: 489–501, 1991
Terent A. Medico-social consequences and direct costs of stroke in a Swedish community. Scandinavian Journal of Rehabilitation Medicine 15: 165–171, 1983
Terent A. Increasing incidence of stroke among Swedish women. Stroke 19: 598–603, 1988
Terent A. Survival after stroke and Transient Ischemic Attacks during the 1970’s and 1980’s. Stroke 20: 1320–1326, 1989
Thompson D, Oster G. Cost-effectiveness of drug therapy for hypercholesterolaemia: a review of the literature. PharmacoEconomics 2: 34–42, 1992
Thorngren M, Westling B. Utilization of health care resources after stroke: a population-based study of 258 hospitalized cases followed during the first year. Acta Neurologica Scandinavica 84: 303–310, 1991
TRUST Study Group Randomised, double-blind, placebo-controlled trial of nimodipine in acute stroke. Lancet 336: 1205–1209, 1990
Tuomilehto J, Nissinen A, Wolf E, Geboers J, Piha T. Effectiveness of treatment with antihypertensive drugs and trends in mortality from stroke in the community. British Medical Journal 291: 857–860, 1985
Turpie AGG, Bloch R, Duke R. Heparin in the treatment of thromboembolic stroke. Annals of the New York Academy of Sciences 556: 406–415, 1989
US Bureau of the Census, Center for International Research, International Data Base on Aging, 1987
VanMerwijk G, Lodder J, Bamford J, Kester ADM. How often is non-valvular atrial fibrillation the cause of brain infarction? Journal of Neurology 237: 205–207, 1990
Verrone GA. Financial expenditures for the care of cerebrovascular disease patients in an urban setting. Public Health Reports 92: 272–279, 1977
Viitanen M, Eriksson S, Asplund K. Risk of recurrent stroke, myocardial infarction and epilepsy during long-term follow-up after stroke. European Neurology 28: 227–231, 1988
Wachtel T, Moulton AW, Pezzullo J, Hamolsky M. Inpatient management protocols to reduce health care costs. Medical Decision Making 6: 101–109, 1986
Wade DT, Skilbeck CE, Hewer RL, Wood VA. Therapy after stroke: amounts, determinants and effects. International Rehabilitation Medicine. 6: 105–110, 1984
Wade DT, Hewer RL, Skilbeck CE, Bainton D, Burns-Cox C. Controlled trial of a home-care service for acute stroke patients. Lancet 1: 323–326, 1985
Wade DT, Hewer RL. Functional abilities after stroke: measurement, natural history and prognosis. Journal of Neurology, Neurosurgery and Psychiatry 50: 177–182, 1987
Wade DT, Skilbeck C, Hewer RL. Selected cognitive losses after stroke: frequency, recovery and prognostic importance. International Disability Studies 11: 34–39, 1989
Wade DT, Collen FM, Robb GF, Warlow CP. Physiotherapy intervention late after stroke and mobility. British Medical Journal 304: 609–613, 1992
Warlow C, Ogston D, Douglas AS. Deep venous thrombosis of the legs after strokes. Part I — Incidence and predisposing factors, & Part II — Natural history. British Medical Journal 1: 1178–1183, 1976
Warlow C. Carotid endarterectomy: Does it work? Stroke 15: 1068–1076, 1984
Weill C, Schneider T. The cost of cerebrovascular accidents in France in 1982. Rose FC (Ed.) Stroke: epidemiological, therapeutic and socio-economic aspects, Royal Society of Medicine Services International Congress and Symposium Series 99, London, 1986
Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine 296: 716–721, 1977
Weinstein MC. Principles of cost-effective resource allocation in health care organizations. International Journal of Technology Assessment in Health Care 6: 93–103, 1990
Weisberg LA, Nice CN. Intracranial tumors simulating the presentation of cerebrovascular syndromes: early detection with cerebral computed tomography (CCT). American Journal of Medicine. 63: 517–524, 1977
Wikstrand J, Warnold I, Olsson G, Tuomilehto J, Elmfeldt D, et al. Primary prevention with metoprolol in patients with hypertension: mortality results fromthe MAPHY study. Journal of the American Medical Association 259: 1976–1982, 1988
Wood-Dauphinee S, Shapiro S, Bass ER, Fletcher C, Georges P, Hensby V, Mendelsohn B. A randomized trial of team care following stroke. Stroke 15: 864–872, 1984
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dunbabin, D. Cost-Effective Intervention in Stroke. PharmacoEconomics 2, 468–499 (1992). https://doi.org/10.2165/00019053-199202060-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199202060-00007